Evergreen Theragnostics raises $15m from Series B round : vi

Evergreen Theragnostics, a clinical stage contract development and manufacturing organisation (CDMO), has completed capital raise of $15m from Series B round.

Related Keywords

New Jersey , United States , James Cook , Thomas Reiner , Novartis Company , Radioligand Therapy Drug Discovery , Advanced Accelerator Applications , Evergreen Theragnostics , Evergreen Discovery ,